Newron Pharmaceuticals S.p.A. (NP5.DE) XETRA

7.42

-0.05(-0.67%)

Updated at August 19 09:29AM

Currency In EUR

Valuation

Market Cap174.68M
Enterprise Value218.21M
P/E Ratio8.79
PEG Ratio0.05
Price/Sales Ratio2.91
Price/Book Ratio95.52
Enterprise/Revenue3.76
Enterprise/EBITDA7.45

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin0.31
Operating Margin0.51

Management Effectiveness

Return On Assets0.25
Return On Equity-1.08

Income Statement

Revenue51.39M
Revenue/Share2.77
Gross Profit51.39M
EBITDA25.94M
Net Income15.84M
Diluted EPS0.85

Balance Sheet

Total Cash9.83M
Total Cash/Share0.53
Total Debt50.47M
Total Debt/Equity34.62
Current Ratio2.6
Book Value Per Share0.08

Price History

52-Week Change-7.43
52-Week High11.5
52-Week Low6.03
Moving Average 50 Days7.6
Moving Average 200 Days8.5

Statistics

Average Volume2,289
Shares Outstanding19.96M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A